ATC codes:
L01CB01
EMLc
Indication
Ewing sarcoma of bone and articular cartilage of unspecified sites
ICD11 code:
2C22.Z
INN
Etoposide
Medicine type
Chemical agent
List type
Complementary
(EML)
(EMLc)
(EMLc)
Formulations
Parenteral > General injections > IV:
20 mg per mL in 5 mL ampoule ;
100 mg in vial powder for injection (as phosphate)
Oral > Solid: 100 mg capsule ; 50 mg capsule
Oral > Solid: 100 mg capsule ; 50 mg capsule
EML status history
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended the inclusion of an additional dose form of etoposide (Powder for injection: 100 mg (as phosphate) in vial) to the EML and EMLc.